# Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice

> **NCT02698124** · — · UNKNOWN · sponsor: **Ulsan University Hospital** · enrollment: 136 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Elderly
- Intensive Chemotherapy Unfit

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT02698124
- **Lead sponsor:** Ulsan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2019-08
- **Final completion:** 2022-12
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2016-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02698124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02698124, "Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02698124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*